Roth/MKM analysts adjusted their outlook on Intel Corporation (NASDAQ:INTC) by reducing the stock's price target from $25.00 to $20.00, while continuing to hold a Neutral rating on the shares.

Roth MKM analyst Suji Desilva lowered the firm’s price target on Intel (INTC) to $20 from $25 and keeps a Neutral rating on the shares. The ...

Roth MKM raised the firm’s price target on TKO Group (TKO) to $185 from $148 and keeps a Buy rating on the shares. The firm remains positive on ...

Roth MKM analyst Scott Stember reiterated a Buy rating on Brunswick (BC – Research Report) today and set a price target of $85.00. The ...

We recently published a list of 10 Unstoppable Stocks to Buy in 2025. In this article, we are going to take a look at where ...

These four Buy-rated stocks are trading under $10 and could offer patient investors enormous returns for 2025 and beyond.

Roblox (NYSE:RBLX – Free Report) had its target price lifted by Roth Mkm from $54.00 to $70.00 in a research report report ...

Roth Mkm restated their buy rating on shares of TriSalus Life Sciences (NASDAQ:TLSI – Free Report) in a research report ...

https://www.tipranks.com/news/the-fly/group-1-automotive-price-target-raised-to-495-from-442-at-guggenheim Roth MKM lowered the firm’s price target on Mattel (MAT ...

Friday - Shares of Verona Pharma (NASDAQ:VRNA) received a positive outlook from Roth/MKM as the firm initiated coverage with a Buy rating and a 12-month price target of $68. The bullish stance is ...